Skip to content

Cost-effectiveness of Two Painkillers for Treating Pain After Limb Injuries

Cost-effectiveness Analysis of Oral Paracetamol and Ibuprofen for Treating Pain After Soft Tissue Limb Injuries: Double-blind, Randomised Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00528658
Enrollment
782
Registered
2007-09-12
Start date
2005-01-31
Completion date
2008-12-31
Last updated
2021-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft Tissue Injuries

Keywords

Soft Tissue Injuries

Brief summary

Background: Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are commonly used oral analgesics in emergency departments (ED) not only in Hong Kong but throughout the world. There are no large-scale (n\>100), prospective, randomised studies comparing paracetamol with ibuprofen in the management of acute soft tissue injury. As paracetamol is cheaper than most NSAIDs, may be as effective in the management of acute pain and possibly with fewer adverse effects, a large-scale, randomised, controlled trial is needed to answer questions of relative analgesic efficacy, safety and cost-effectiveness. Previous comparative studies on NSAIDS have been done in this unit and have suggested equivalence between two NSAIDs and paracetamol, but numbers were small and drug doses were modest. Objective: To compare the efficacy, safety and cost between oral ibuprofen and paracetamol in pain control for acute soft tissue injuries in an ED setting Design: Prospective, double-blind, randomised controlled trial with three arms: oral paracetamol with placebo; oral ibuprofen with placebo; paracetamol and ibuprofen in combination Participants: 783 subjects having sustained isolated soft tissue limb injury without significant fracture presenting to the ED of Prince of Wales Hospital Main outcome measures: Pain relief profiles of paracetamol, ibuprofen and the combination of both; adverse effect profiles of paracetamol, ibuprofen and the combination of both; overall cost effectiveness of paracetamol, ibuprofen and the combination of both from the perspective of the healthcare provider

Interventions

equivalent to 1g qid

Equivalent to 400mg tid

DRUGIbuprofen

400mg tid

DRUGParacetamol

1g qid

Sponsors

Hong Kong Academy of Medicine
CollaboratorOTHER
Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* All patients \>16 years presenting to the ED with isolated soft tissue injury without significant fracture * between 9am to 5pm, Monday to Friday,

Exclusion criteria

* History of : * peptic ulceration or hemorrhage * recent anticoagulation * pregnancy * adverse reaction to paracetamol or ibuprofen * renal or cardiac failure * hepatic problems * rectal bleeding * chronic NSAID consumption * asthma * chronic obstructive pulmonary disease * chronic pain syndromes * prior treatment with analgesia for the same injury * physical, visual or cognitive impairment making use of the visual analogue scale unreliable

Design outcomes

Primary

MeasureTime frame
analgesic efficacy both at rest and with movement72 hours

Secondary

MeasureTime frame
presence, frequency and duration of adverse effects; cost-effectiveness analysis; patient satisfaction with analgesia30 days

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026